Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $127.41 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $34.92 | 2 | $0 (2024) |
| Novo Nordisk Inc | $33.76 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $26.46 | 1 | $0 (2023) |
| Exact Sciences Corporation | $18.55 | 1 | $0 (2024) |
| EISAI INC. | $13.72 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.84 | 3 | Novo Nordisk Inc ($21.91) |
| 2023 | $26.46 | 1 | Otsuka America Pharmaceutical, Inc. ($26.46) |
| 2022 | $27.39 | 2 | Lilly USA, LLC ($15.54) |
| 2021 | $13.72 | 1 | EISAI INC. ($13.72) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.91 | General |
| 04/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Oncology | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 04/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Diabetes | ||||||
| 08/17/2021 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.72 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 205 | 214 | $32,985 | $9,916 |
| 2022 | 10 | 280 | 300 | $49,120 | $15,622 |
| 2021 | 6 | 156 | 156 | $29,196 | $6,851 |
| 2020 | 3 | 186 | 190 | $30,182 | $11,340 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 101 | $15,797 | $4,815 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $8,960 | $1,755 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $4,120 | $1,420 | 34.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 27 | 27 | $1,890 | $1,382 | 73.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 14 | $1,876 | $505.26 | 26.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 18 | $342.00 | $39.60 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 102 | 118 | $18,426 | $6,366 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $11,226 | $2,882 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $3,854 | $1,461 | 37.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $5,115 | $1,398 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,176 | $1,277 | 30.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 36 | 38 | $2,660 | $1,156 | 43.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 14 | $1,876 | $475.01 | 25.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $897.00 | $452.56 | 50.5% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $517.00 | $107.73 | 20.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 21 | $373.00 | $46.63 | 12.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $11,607 | $2,493 | 21.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 40 | $7,971 | $1,822 | 22.9% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 27 | 27 | $3,687 | $953.91 | 25.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $3,072 | $815.38 | 26.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 19 | $2,715 | $730.46 | 26.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 16 | 16 | $144.00 | $36.00 | 25.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 86 | 86 | $15,136 | $5,922 | 39.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 85 | $14,875 | $5,375 | 36.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 19 | 19 | $171.00 | $42.55 | 24.9% |
About David Zuckerman, PA-C
David Zuckerman, PA-C is a Medical healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982075073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Zuckerman, PA-C has received a total of $127.41 in payments from pharmaceutical and medical device companies, with $59.84 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($127.41).
As a Medicare-enrolled provider, Zuckerman has provided services to 827 Medicare beneficiaries, totaling 860 services with total Medicare billing of $43,729. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Zebulon, NC
- Active Since 10/14/2015
- Last Updated 12/23/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1982075073
Products in Payments
- MOUNJARO (Drug) $34.92
- REXULTI (Drug) $26.46
- Cologuard Collection Kit (Device) $18.55
- Dayvigo (Drug) $13.72
- Rybelsus (Drug) $11.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.